Tove Wästerlid

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Jag är specialistläkare i Hematologi vid Karolinska Universitetssjukhuset samt docent i hematologi, verksam i gruppen för cancerepidemiologi på KEP. Jag forskar både epidemiologiskt och molekylärbiologiskt om lymfom. För mer information om min forskning, publikationer och undervisning se den engelska versionen av den här sidan.

Artiklar

Journal article: AMERICAN JOURNAL OF HEMATOLOGY. 2025
Association of Pre-Diagnostic Clonal Hematopoiesis of Indeterminate Potential With Prognosis Among Patients With Cancer
Liu X; Adami H-O; Wasterlid T; Xue H; Feychting M; Smedby KE; Fang F; Liu Q
Article: JOURNAL OF INTERNAL MEDICINE. 2025;297(6):672-682
Clonal hematopoiesis of indeterminate potential and risk of immune thrombocytopenia
Liu Q; Wasterlid T; Smedby KE; Xue H; Boberg E; Fang F; Liu X
Article: HEALTH INFORMATICS JOURNAL. 2024;30(4):14604582241290725
Smart variant filtering - A blueprint solution for massively parallel sequencing-based variant analysis
Brahimllari O; Eloranta S; Georgii-Hemming P; Haider Z; Koch S; Krstic A; Skarp FP; Rosenquist R; Smedby KE; Taylan F; Thorvaldsdottir B; Wirta V; Wasterlid T; Boman M
Article: ECLINICALMEDICINE. 2024;74:102753
Clonal hematopoiesis of indeterminate potential and the risk of pulmonary embolism: an observational study
Liu Q; Smedby KE; Xue H; Waesterlid T; Li J; Fang F; Liu X
Article: ACTA ONCOLOGICA. 2024;63:563-572
The National Swedish Lymphoma Register - a systematic validation of data quality
Smedby KE; Eloranta S; Wasterlid T; Falini V; Jerlstrom U; Ellin F; Papworth K; Westerberg J; Lewerin C; Andersson P-O; Kristjansdottir HL; Brandefors L; Morth C-L; Hallen K; Kuric N; Abu Sabaa A; Wahlin BE; Molin D; Enblad G; Horsted A-S; Jerkeman M; Glimelius I
Article: EJHAEM. 2024;5(3):516-526
Treatment sequencing and impact of number of treatment lines on survival in follicular lymphoma: A national population-based study
Wasterlid T; Dietrich CE; Oksanen A; Spangberg LD; Wahlin BE; Enblad G; Andersson P-O; Kimby E; Smedby KE
Article: CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY. 2024;46:100785
Stable use of radiotherapy in lymphoma patients over time - A comprehensive national overview of radiotherapy use in Sweden with focus on older patients
Glimelius I; Ekberg S; Smedby KE; Wasterlid T
Article: ACTA ONCOLOGICA. 2024;63:164-168
Impact of the COVID-19 pandemic on lymphoma incidence and short-term survival - a Swedish Lymphoma Register Study
Ekberg S; Molin D; Pahnke S; Bergstroem F; Branvall E; Smedby KE; Waesterlid T
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2024;204(3):967-975
Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population-based study
Baech J; Husby S; Trab T; Kragholm K; Brown P; Gorlov JS; Jorgensen JM; Gudbrandsdottir S; Severinsen MT; Gronbaek K; Larsen TS; Wasterlid T; Eloranta S; Smeland KB; Jakobsen LH; El-Galaly TC
Article: HEMASPHERE. 2023;7(3):e838
Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden
Weibull CE; Wasterlid T; Wahlin BE; Andersson P-O; Ekberg S; Lockmer S; Enblad G; Crowther MJ; Kimby E; Smedby KE
Article: FRONTIERS IN ONCOLOGY. 2023;13:1176698
Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study
Haider Z; Wasterlid T; Spangberg LD; Rabbani L; Jylha C; Thorvaldsdottir B; Skaftason A; Awier HN; Krstic A; Gellerbring A; Lyander A; Hagglund M; Jeggari A; Rassidakis G; Sonnevi K; Sander B; Rosenquist R; Tham E; Smedby KE
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2023;98(1):23-30
Sex differences in lymphoma incidence and mortality by subtype: A population-based study
Radkiewicz C; Bruchfeld JB; Weibull CE; Jeppesen ML; Frederiksen H; Lambe M; Jakobsen L; El-Galaly TC; Smedby KE; Wasterlid T
Article: BRITISH JOURNAL OF CANCER. 2022;127(10):1808-1815
Standardised survival probabilities: a useful and informative tool for reporting regression models for survival data
Syriopoulou E; Wasterlid T; Lambert PC; Andersson TM-L
Journal article: ANNALS OF LYMPHOMA. 2022;0(0):0
Diffuse large B-cell lymphoma among the elderly: a narrative review of current knowledge and future perspectives
Wästerlid T; Murphy S; Villa D; El-Galaly TC
Article: BLOOD ADVANCES. 2022;6(8):2657-2666
Incidence and time trends of second primary malignancies after non-Hodgkin lymphoma: a Swedish population-based study
Joelsson J; Wasterlid T; Rosenquist R; Jakobsen LH; El-Galaly TC; Smedby KE; Eloranta S
Article: FRONTIERS IN ONCOLOGY. 2022;12:984021
Data-driven support to decision-making in molecular tumour boards for lymphoma: A design science approach
Ruiz NR; Abd Own S; Smedby KE; Eloranta S; Koch S; Wasterlid T; Krstic A; Boman M
Article: EJHAEM. 2021;2(4):774-784
Excellent survival after R-Hyper-CVAD in hospitalized patients with high-risk large B-cell lymphoma: The Karolinska experience
Sonnevi K; Ljungqvist M; Joelsson JK; Harrysson S; Wasterlid T; Bernell P; Wahlin BE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;195(4):552-560
Statin use and survival in 16 098 patients with non-Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era
Branvall E; Ekberg S; Eloranta S; Wasterlid T; Birmann BM; Smedby KE
Article: EJHAEM. 2021;2(3):525-529
Temporary cessation of ibrutinib results in reduced grade 3-4 infections and durable remissions-Interim analysis of an on-off-repeat Phase 1b/2 study in patients with chronic lymphocytic leukemia
Lundin J; Mulder TA; Kattstrom M; Wasterlid T; Uddevik A; Mellstedt H; Heimersson K; Hansson L; Palma M; Osterborg A
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;192(3):551-559
Clinical characteristics and outcomes among 2347 patients aged ≥85 years with major lymphoma subtypes: a Nordic Lymphoma Group study
Wasterlid T; Oren Gradel K; Eloranta S; Glimelius I; El-Galaly TC; Frederiksen H; Smedby KE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;192(1):75-81
Survival of very elderly patients with diffuse large B-cell lymphoma according to treatment intensity in the immunochemotherapy era: a Swedish Lymphoma Register study
Sonnevi K; Wasterlid T; Melen CM; Harrysson S; Smedby KE; Wahlin BE
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2020;95(7):740-748
Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma
Wasterlid T; Harrysson S; Andersson TM-L; Ekberg S; Enblad G; Andersson P-O; Jerkeman M; Eloranta S; Smedby KE
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2020;95(6):652-661
Statin use is associated with improved survival in multiple myeloma: A Swedish population-based study of 4315 patients
Branvall E; Ekberg S; Eloranta S; Wasterlid T; Birmann BM; Smedby KE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;189(4):661-671
Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real-world patients
Jakobsen LH; Ellin F; Smeland KB; Wasterlid T; Christensen JH; Jorgensen JM; Josefsson PL; Ovlisen AK; Holte H; Blaker YN; Grauslund JH; Bjorn J; Molin D; Lagerlof I; Smedby KE; Colvin K; Thanarajasingam G; Maurer MJ; Habermann TM; Song KW; Zhu KY; Gerrie AS; Cheah CY; El-Galaly TC
Journal article: BLOOD. 2019;134:4113
Inferior Outcomes for Older Patients in the Adolescent and Young Adult (AYA) Population with Burkitt Lymphoma Treated with Intensive Immunochemotherapy: An International Study of 108 Patients
Ellin F; Smeland KB; Wasterlid T; Christensen JH; Jorgensen J; Josefsson PL; Holte H; Blaker YN; Grauslund JH; Bjoern J; Molin D; Lagerlof I; Smedby KEE; Colvin K; Thanarajasingam G; Maurer MJ; Habermann TM; Song K; Zhu KY; Gerrie AS; Cheah CY; El-Galaly TCC; Jakobsen LH
Article: JOURNAL OF INTERNAL MEDICINE. 2019;285(4):455-468
Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B-cell lymphoma: a Swedish lymphoma register study
Wasterlid T; Mohammadi M; Smedby KE; Glimelius I; Jerkeman M; Bottai M; Eloranta S
Journal article: BLOOD. 2018;132:452
Normalization of Survival and No Relapses after One Year in Adult Burkitt Lymphoma Patients Treated with Intensive Immunochemotherapy: An International Study of 159 Real-World Patients
Jakobsen LH; Ellin F; Smeland KB; Wasterlid T; Christensen JH; Jorgensen J; Josefsson PL; Holte HJ; Blaker YN; Grauslund JH; Bjorn J; Molin D; Lagerlof I; Smedby KE; Colvin K; Thanarajasingam G; Gerrie AS; Cheah CY; El-Galaly TC
Article: HEMATOLOGICAL ONCOLOGY. 2017;35(2):151-157
Impact on survival of addition of etoposide to primary chemotherapy in diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study
Wasterlid T; Hartman L; Szekely E; Jerkeman M
Journal article: BLOOD. 2015;126(23):5039
Frequency and Clinical Implication of SOX11 Expression in Burkitt Lymphoma
Wasterlid T; Nordstrom L; Pedersen M; Norgaard PH; Gang AO; Brown PDN; Jerkeman M; Ek S
Journal article: BLOOD. 2014;124(21):4427
R-CHOEP-14 Is Associated with Superior Overall Survival Compared to R-CHOP-21 and R-CHOP-14 in Patients with DLBCL ≤ 70 Years - a Swedish Lymphoma Registry Population Based Study
Wasterlid T; Szekely E; Hartman LW; Jerkeman M
Article: ANNALS OF ONCOLOGY. 2013;24(7):1879-1886
Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group
Wasterlid T; Brown PN; Hagberg O; Hagberg H; Pedersen LM; D'Amore F; Jerkeman M
Article: LEUKEMIA & LYMPHOMA. 2011;52(11):2090-2096
Population based study of prognostic factors and treatment in adult Burkitt lymphoma: a Swedish Lymphoma Registry study
Wasterlid T; Jonsson B; Hagberg H; Jerkeman M
Visa fler

Anställningar

Anknuten till Forskning, Medicin, Solna, Karolinska Institutet, 2017-2026
Anknuten till Forskning, Medicin, Solna, Karolinska Institutet, 2024-2025
ST-läkare Hematologi, Department of Hematology, Karolinska University Hospital, 2017-2023

Examina och utbildning

Docent, hematologi, Karolinska Institutet, 2025

Handledning

Erik Boberg, 2023
Linn Deleskog Spångberg, 2022
Johanna Borg Bruchfeld, Sex-related differences in incidence and outcomes among patients with lymphoma: epidemiological and biological perspectives, https://ki.se/en/people/johanna-borg-bruchfeld, 2021
Joel Joelsson, 2019

Om mig

Artiklar

Anställningar

Examina och utbildning

Handledning

Nyheter från KI

Kalenderhändelser från KI